Aducanumab Update

While various opinions are circulating, and the benefits of this drug are unclear, ANA will continue to monitor the situation and provide updates as information becomes available.

MRI

Alzheimer’s Disease: Mystery No More

It was once so common to be forgetful in old age that it was thought to be normal. But normal aging only includes things like tip-of-tongue memory loss and forgetting faces.

Trailblazer clinical trial featured in New York Times

In the narrow window in which patients are aware of their disease, they have sought help in clinical trials. But enrolling enough participants to make these trials count is not easy.

ANA Presentation at CTAD 2020

The Clinical Research Center staff presented their findings at the 13th Clinical Trials on Alzheimer’s Disease Conference.